Etude : Owkin révèle comment l’IA redéfinit les pratiques despathologistes face aux défis du secteur
NETRIS Pharma Welcomes Eric Falcand as Independent Director to Its Board of Directors
NETRIS Pharma Receives Best Biotech Pitch Award at EIC and Johnson & Johnson Healthcare Investor Day (powered by Bpifrance – Euroquity)
NETRIS Pharma Announces FDA Orphan Drug Designation (ODD) for NP137 in Pancreatic Cancer Treatment
